3D Printed Drugs Market Key Highlights and Future Opportunities Till 2035
Pharmaceutical manufacturing has traditionally relied on highly standardized processes designed for large production volumes. 3D printing introduces a different approach by allowing medicines to be constructed layer by layer, potentially enabling greater control over dosage, geometry and drug-release characteristics.
The global 3D printed drugs market was valued at approximately USD 281.63 million in 2024 and is projected to reach USD 605.09 million by 2035, representing a CAGR of 7.20%.
お気に入り
コメント
シェア